The EME Programme Efficacy and Mechanism Evaluation Programme EME - - PowerPoint PPT Presentation

the eme programme
SMART_READER_LITE
LIVE PREVIEW

The EME Programme Efficacy and Mechanism Evaluation Programme EME - - PowerPoint PPT Presentation

The EME Programme Efficacy and Mechanism Evaluation Programme EME webinar 2017 www.nihr.ac.uk The EME Programme Where EME fits into UK biomedical research funding What will EME fund? What wont EME fund? The EME Programme


slide-1
SLIDE 1

www.nihr.ac.uk Efficacy and Mechanism Evaluation Programme

EME webinar 2017

The EME Programme

slide-2
SLIDE 2

www.nihr.ac.uk

The EME Programme

  • Where EME fits into UK biomedical research funding
  • What will EME fund?
  • What won’t EME fund?
  • The EME Programme vision
  • The application/funding process
slide-3
SLIDE 3

www.nihr.ac.uk

The EME Programme

  • Where EME fits into UK biomedical research funding
  • What will EME fund?
  • What won’t EME fund?
  • The EME Programme vision
  • The application/funding process
slide-4
SLIDE 4

www.nihr.ac.uk

Preclinical laboratory science First in man studies Efficacy studies Effectiveness studies

Idea

MRC/NIHR clinical research: the Managed Translational Pathway

MRC MRC BRCs BRUs EME HTA

The EME Programme

slide-5
SLIDE 5

www.nihr.ac.uk

MRC Can it work? EME Does it work? HTA Is it worth it?

MRC/NIHR clinical research In simple terms:

Efficacy Effectiveness Discovery science and “first in man”

The EME Programme

slide-6
SLIDE 6

www.nihr.ac.uk

  • Where EME fits into UK biomedical research funding
  • What will EME fund?
  • What won’t EME fund?
  • The EME Programme vision
  • The application/funding process

The EME Programme

slide-7
SLIDE 7

www.nihr.ac.uk

The EME Programme

What will EME support?

  • Research to determine proof of clinical efficacy, size of effect, and

safety in a well-defined population.

  • The evaluation of a broad range of interventions which have the

potential to maintain health, treat disease or improve recovery.

  • Hypothesis-driven research based on an efficacy study, to explore

the mechanisms of action of interventions, causes of differing responses or disease mechanisms.

  • Studies using novel or infrequently-used study designs which

increase the value of a study, by maximising the chances of demonstrating the benefit of an intervention, increasing the knowledge that can be gained

slide-8
SLIDE 8

www.nihr.ac.uk

The EME Programme

What will EME support?

  • Research to determine proof of clinical efficacy, size of effect, and

safety in a well-defined population.

  • The evaluation of a broad range of interventions which have the

potential to maintain health, treat disease or improve recovery.

  • Hypothesis-driven research based on an efficacy study, to explore

the mechanisms of action of interventions, causes of differing responses or disease mechanisms.

  • Studies using novel or infrequently-used study designs which

increase the value of a study, by maximising the chances of demonstrating the benefit of an intervention, increasing the knowledge that can be gained

slide-9
SLIDE 9

www.nihr.ac.uk

The EME Programme

What will EME support?

  • Research to determine proof of clinical efficacy, size of effect, and

safety in a well-defined population.

  • The evaluation of a broad range of interventions which have the

potential to maintain health, treat disease or improve recovery.

  • Hypothesis-driven research based on an efficacy study, to explore

the mechanisms of action of interventions, causes of differing responses or disease mechanisms.

  • Studies using novel or infrequently-used study designs which

increase the value of a study, by maximising the chances of demonstrating the benefit of an intervention, increasing the knowledge that can be gained

slide-10
SLIDE 10

www.nihr.ac.uk

The EME Programme

What will EME support?

  • Research to determine proof of clinical efficacy, size of effect, and

safety in a well-defined population.

  • The evaluation of a broad range of interventions which have the

potential to maintain health, treat disease or improve recovery.

  • Hypothesis-driven research based on an efficacy study, to explore

the mechanisms of action of interventions, causes of differing responses or disease mechanisms.

  • Studies using novel or infrequently-used study designs which

increase the value of a study, by maximising the chances of demonstrating the benefit of an intervention, increasing the knowledge that can be gained

slide-11
SLIDE 11

www.nihr.ac.uk

The EME Programme

  • Embedded pilot and feasibility studies where the main study would

be within the remit of the EME programme.

Ways to increase “pull through” of studies

slide-12
SLIDE 12

www.nihr.ac.uk

The EME Programme

  • Embedded pilot and feasibility studies where the main study would

be within the remit of the EME programme.

  • The final development of an intervention prior to proceeding to the

main clinical evaluation within the same application.

Ways to increase “pull through” of studies

slide-13
SLIDE 13

www.nihr.ac.uk

The EME Programme

  • Embedded pilot and feasibility studies where the main study would

be within the remit of the EME programme.

  • The final development of an intervention prior to proceeding to the

main clinical evaluation within the same application.

  • Proposals that include a series of linked stages with progression to

the main clinical evaluation dependent on the outcome of the previous stage(s).

Ways to increase “pull through” of studies

slide-14
SLIDE 14

www.nihr.ac.uk

  • Where EME fits into UK biomedical research funding
  • What will EME fund?
  • What won’t EME fund?
  • The EME Programme vision
  • The application/funding process

The EME Programme

slide-15
SLIDE 15

www.nihr.ac.uk

The EME Programme

  • Large effectiveness studies that test the impact of the introduction of

an intervention in the wider NHS

  • Hypothesis-generating studies, e.g. biomarker discovery
  • Confirmatory studies or minor modifications
  • Research into areas where the health need is identified primarily
  • utside the UK.
  • Any research involving animals or animal tissues.

What will EME not support?

slide-16
SLIDE 16

www.nihr.ac.uk

The EME Programme

  • Large effectiveness studies that test the impact of the introduction of

an intervention in the wider NHS.

  • Hypothesis-generating studies, e.g. biomarker discovery
  • Confirmatory studies or minor modifications
  • Research into areas where the health need is identified primarily
  • utside the UK
  • Any research involving animals or animal tissues.

What will EME not support?

slide-17
SLIDE 17

www.nihr.ac.uk

The EME Programme

  • Large effectiveness studies that test the impact of the introduction of

an intervention in the wider NHS.

  • Hypothesis-generating studies, e.g. biomarker discovery
  • Confirmatory studies or minor modifications
  • Research into areas where the health need is identified primarily
  • utside the UK
  • Any research involving animals or animal tissues.

What will EME not support?

slide-18
SLIDE 18

www.nihr.ac.uk

The EME Programme

  • Large effectiveness studies that test the impact of the introduction of

an intervention in the wider NHS.

  • Hypothesis-generating studies, e.g. biomarker discovery
  • Confirmatory studies or minor modifications
  • Research into areas where the health need is identified primarily
  • utside the UK.
  • Any research involving animals or animal tissues.

What will EME not support?

slide-19
SLIDE 19

www.nihr.ac.uk

The EME Programme

  • Large effectiveness studies that test the impact of the introduction of

an intervention in the wider NHS.

  • Hypothesis-generating studies, e.g. biomarker discovery
  • Confirmatory studies or minor modifications
  • Research into areas where the health need is identified primarily
  • utside the UK
  • Any research involving animals or animal tissues.

What will EME not support?

slide-20
SLIDE 20

www.nihr.ac.uk

  • Where EME fits into UK biomedical research funding
  • What will EME fund?
  • What won’t EME fund?
  • The EME Programme vision
  • The application/funding process

The EME Programme

slide-21
SLIDE 21

www.nihr.ac.uk

The EME Programme

To continue to fund ambitious projects which include new ways of delivering clinical studies that could:

  • Maximise the potential gain from the research
  • Reduce the time or cost to evaluate promising new interventions
  • Increase the breadth of the programmes portfolio in terms of the

types of interventions being evaluated and the methodologies being used

  • Increase the number and extent of collaborations, acknowledging

that there is a potential for very large and ambitious studies

The programme vision

slide-22
SLIDE 22

www.nihr.ac.uk

The EME Programme

  • Patient stratification
  • Methodological innovation
  • Broader diversity of interventions
  • Novel use of information enabled by digital technology

We are particularly interested in studies with:

slide-23
SLIDE 23

www.nihr.ac.uk

The EME Programme

  • Where EME fits into UK biomedical research funding
  • What will EME fund?
  • What won’t EME fund?
  • The EME Programme vision
  • The application/funding process
slide-24
SLIDE 24

The Efficacy and Mechanism Evaluation Programme (EME):

The Application Process & Hints & Tips for Getting it Right

slide-25
SLIDE 25

www.nihr.ac.uk

The EME Programme

Funding applications:

  • Can be a researcher’s idea (“Researcher led”)
  • Can be in response to our call for research in a particular area

(“Commissioned”)

  • Nearly always two stage (outline and full applications)
slide-26
SLIDE 26

www.nihr.ac.uk

The EME Programme

Outline application Pre-filter (Remit & competitiveness panel) Reviewer(s) Designated Board Members (DBMs) selected Board meeting Outcome letter

Outline Web form

Outline application process

slide-27
SLIDE 27

www.nihr.ac.uk

The EME Programme

Full application Reviewer(s) Applicant responds to reviewer(s) Designated Board Members (DBMs) usually retained from outline Board meeting Final outcome letter Contract

Full application process

Full application Web form

slide-28
SLIDE 28

www.nihr.ac.uk

Research Question:

  • Is it the most important question, clearly defined in simple terms,

ideally in one sentence? – Has the question already been answered? – Has a similar project already been funded by the funders? – Does it matter to patients/public? – Is it timely and will it make a difference? – Can it be delivered by the NHS/Social Care?

Key Considerations

slide-29
SLIDE 29

www.nihr.ac.uk

Study Design:

  • Is the design optimised to answer the question?

– Use existing support, e.g. RDS – Choose the most robust research method and describe it clearly and fully – Ensure your choice of primary outcome, and any secondary

  • utcomes are clear

– Statistical input: can your sample size/power calculation be replicated? – Explain the dosage and any side effects of the intervention

slide-30
SLIDE 30

www.nihr.ac.uk

Multi-disciplinary team:

  • Do you have the expertise you need?

– Ensure the roles are clearly defined and appropriate – Consider the level and range of expertise required – Ensure that PPI is demonstrated at all stages

slide-31
SLIDE 31

www.nihr.ac.uk

Deliverability:

  • Have you ensured your research is credible?

– Recruitment: have you made a convincing case that your recruitment plan is realistic? – Is your timeline manageable? – Does your application provide value for money, and are the costs correctly allocated?

slide-32
SLIDE 32

www.nihr.ac.uk

  • Is there a clear pathway to dissemination and impact?

– What are the next steps involved after the project has completed? – How will the research impact current practice?

Research Dissemination & Impact:

slide-33
SLIDE 33

www.nihr.ac.uk

  • Have you followed the feedback, or made a robust defence for why

you disagree? – External Reviewers – Board Members

Feedback

slide-34
SLIDE 34

www.nihr.ac.uk

Contact details: Useful resources https://www.nihr.ac.uk/funding-and-support/funding-for-research- studies/funding-programmes/efficacy-and-mechanism-evaluation/

Direct email Telephone number eme@nihr.ac.uk +44 (0)23 8059 4303

slide-35
SLIDE 35

www.nihr.ac.uk

Any Questions?